Health
Maker seeking Indian trial of Novavax jab – McIvor Times
The Serum Institute of India, the world’s biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc’s COVID-19 vaccine, which was found to be 89.3 per cent effective in a UK trial.Serum expected a decision on an Indian trial of Novavax’s vaccine soon, Chief Executive Adar Poonawalla told Reuters on Friday, hours after the US company reported the efficacy data.
“We have already applied to the drug controller’s office for the bridging trial, a few days…
-
Noosa News18 hours agoThe Laundry Lady secures $1M to fuel international expansion
-
General23 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News15 hours agoTruffle growers say rare delicacy is worth its $3,500 per kilo expense
-
Noosa News15 hours agoHomicide investigation underway after woman found dead in north Brisbane